Enlisting Monoclonal Antibodies in the Fight Against COVID-19

Enlisting Monoclonal Antibodies in the Fight Against COVID-19

Enlisting Monoclonal Antibodies in the Fight Against COVID-19Posted on May 21st, 2020 by Dr. Francis CollinsCaption: Antibody Binding to SARS-CoV-2. Monoclonal antibodies are currently used to treat a variety of conditions, including asthma, cancer, Crohn’s disease, and rheumatoid arthritis. In the U.S. and Europe, the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership, which has brought together public and private sector COVID-19 therapeutic and vaccine efforts, is intensely pursuing the development and testing of therapeutic monoclonal antibodies for COVID-19 [4]. 18 May 2020 [Epub ahead of print][4] Accelerating COVID-19 therapeutic interventions and vaccines (ACTIV): An unprecedented partnership for unprecedented times. Links:Coronavirus (COVID-19) (NIH)Monoclonal Antibodies (National Cancer Institute/NIH)Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)NIH Support: National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences

About Us

At Wellness Axis we want to encourage habits of wellness, Increase awareness of factors and resources contributing to well-being, Inspire and empower individuals to take responsibility for their own health, and to support a sense of community. Wellness can be thought of as the quality or state of being in good health.

Subscribe to our newsletter!